CervoMed Inc. (CRVO)

CervoMed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	7.79	4.09	37.31	18.52	14.18
Cash & Cash Equivalents	7.79	4.09	37.31	18.52	14.18
Cash Growth	90.37%	-89.03%	101.53%	30.60%	77.41%
Receivables	0.92	0	0	0	0
Other Current Assets	1.26	0.06	0.51	0.26	0.47
Total Current Assets	9.96	4.16	37.82	18.78	14.65
Property, Plant & Equipment	0	0	0	0.3	0.5
Goodwill and Intangibles	0	0	0	8.64	8.64
Other Long-Term Assets	0.01	0	0.02	0.02	0.32
Total Long-Term Assets	0.01	0	0.02	8.95	9.46
Total Assets	9.97	4.16	37.84	27.73	24.11
Accounts Payable	0.66	0.1	0.95	0.55	1.25
Current Debt	0	12.41	0	0.11	0.11
Other Current Liabilities	1.93	0.64	1.98	1.78	0.36
Total Current Liabilities	2.6	13.16	2.93	2.44	1.72
Long-Term Debt	0	0	0	0.04	0.14
Other Long-Term Liabilities	0	0	0	0.44	2.12
Total Long-Term Liabilities	0	0	0	0.48	2.25
Total Liabilities	2.6	13.16	2.93	2.92	3.98
Total Debt	0	12.41	0	0.15	0.25
Debt Growth	-	-	-	-39.62%	-
Retained Earnings	-54.44	-52.27	-130.01	-105.91	-91.72
Shareholders' Equity	7.38	-33.29	34.91	24.81	20.13
Net Cash / Debt	7.79	-8.32	37.31	18.37	13.93
Net Cash / Debt Growth	-	-	103.16%	31.85%	74.32%
Net Cash Per Share	2.93	-16.06	28.75	25.59	155.79
Working Capital	7.37	-9	34.9	16.34	12.93
Book Value Per Share	2.77	-64.24	26.90	34.57	225.16

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).